WednesdayFeb 22, 2023 12:16 pm

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) CEO Says Cannabis Companies Must Catch up in Benzinga Article

SideChannel (OTCQB: SDCH), a provider of cybersecurity products and services to emerging, middle-market and enterprise companies, was featured in a recent Benzinga article. The piece, titled “EXCLUSIVE: Ex-KGB Cyber Criminals with Ties to Moscow Could Steal Your Cannabis Business Info & Money, Expert Warns,” includes excerpts from an exclusive interview with SDCH founder and CEO Brian Haugli. “Forget the evil nerd in a dark basement. That’s Hollywood. Most likely, if you’re in the cannabis industry, your hackers are part of global organizations that have turned hacking into a lean, mean money-making machine,” the article reads. “Haugli explained that cannabis companies…

Continue Reading

TuesdayFeb 21, 2023 2:42 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) CEO Featured in Recent “Authority” Magazine Interview

HeartBeam (NASDAQ: BEAT) CEO and founder Branislav Vajdic, PhD, is featured in a recent interview with David Leichner that was published in “Authority” magazine. The interview was one of a series of interviews with leaders of tech companies. The series, called “Technology Making an Important Positive Social Impact,” spotlights companies working on making monumental positive changes to society, health, and the environment. In the interview, Vajdic talked about his journey to HeartBeam, including the first half of his career, which was spent as a chip designer with Intel Corporation; Vajdic was involved in the design of the first Flash memory,…

Continue Reading

TuesdayFeb 21, 2023 12:38 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Findings from Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is reporting additional findings from its human clinical study HYPER-H21-4; the study is designed to demonstrate a potentially novel mechanism of action of LEXX’s patented DehydraTECH-processed cannabidiol ("CBD") capsule formulation in the treatment of blood pressure ("BP"). According to the announcement, Lexaria believes that those findings, which were published in the peer-reviewed “Biomedicine and Pharmacotherapy" journal, could support DehydraTECH-CBD qualification within existing Food and Drug Administration (“FDA”) guidelines. Previous results of the study indicated that primary efficacy and safety objectives were successfully achieved, including hypertensive patients seeing resting blood pressure…

Continue Reading

TuesdayFeb 21, 2023 12:28 pm

QualityStocksNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Results of Annual Meeting of Stockholders

FingerMotion (NASDAQ: FNGR), a mobile data and services company, today announced the outcome of matters voted on at its recent annual meeting of stockholders, which took place on Feb. 17, 2023. Among the highlights, Hsien Loong Wong, Yew Poh Leong, Michael Chan and Eng Ho Ng were elected to the company’s board of directors, Centurion ZD CPA & Co. was appointed as FNGR’s independent registered public accounting firm, and the company’s 2023 Stock Incentive Plan, executive compensation and the amendment to the exercise price of outstanding stock options from $8.00 to $3.84 were approved. In addition, FingerMotion’s executive officers were…

Continue Reading

TuesdayFeb 21, 2023 11:35 am

QualityStocksNewsBreaks – SideChannel Inc. (SDCH) Announces Annual Meeting Results, Investor Day Highlights

SideChannel (OTCQB: SDCH), a provider of cybersecurity products and services to emerging, middle-market and enterprise companies, today announced the results of its annual meeting of stockholders and summarized highlights from its Investor Day broadcast, both of which occurred on Feb. 15, 2023. Results of the annual meeting included new board appointments, the ratified appointment of RBSM, LLP as the company’s independent auditor, and the granting of discretionary authority to the board of directors to combine outstanding shares of SideChannel’s common stock into a lesser number of outstanding shares, with the exact ratio to be determined by the board. During the…

Continue Reading

TuesdayFeb 21, 2023 11:29 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Secures Multiple Contracts for Processing Organics at Sea to Sky Soils

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) announced that its Sea to Sky Soils organic waste processing and composting facility has entered multiple contracts with a B.C. regional district for the processing of organic waste at the facility, which provides over 10,000 tonnes per annum. With a track record of operational excellence and sustainable practices, EverGen is one of the top regional processors of organics in B.C. The company’s commitment is to own and operate best-in-class facilities that offer its municipal and commercial partners both cost-effective and environmentally sustainable solutions for processing and recycling organics. “Contracts such as these de-risk our core…

Continue Reading

TuesdayFeb 21, 2023 10:54 am

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Builds on Growing Success with Sales of New K1 Call Boxes

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots and blue light emergency communication systems, sees continued growth through sales of 11 K1 Call Boxes to Larimer County, Colorado. The transaction was completed through KSCP resale partner Stream Speed Technologies (“SST”). Knightscope’s smallest emergency call box system, the K1 Call Box, offers one-touch connection with a ruggedized housing and simple interface. The call box offers a completely wireless solution for emergency phone calls and can also work with existing nearby wiring nearby. In addition, the system includes additional options that allow people who are deaf, hard of hearing or…

Continue Reading

TuesdayFeb 21, 2023 10:37 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q2 2023 Financial, Corporate Report

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, is reporting on its second quarter of fiscal year 2023, the period that ended Dec. 31, 2022. Highlights of the report include the company closing the calendar year with nearly $11.5 million in cash and the completion of enrollment in the company’s phase 2 clinical trial in epidermolysis bullosa (“EB”). The report also noted that the company has seen advancement in its research using rare cannabinoids in the treatment of glaucoma and neurodegenerative diseases such as Alzheimer’s, Huntington’s and Parkinson’s. “This…

Continue Reading

FridayFeb 17, 2023 2:55 pm

QualityStocksNewsBreaks – FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Initiates Testing on Green Ammonia Production System

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) today announced that it commenced system testing on its on-farm, containerized green ammonia production system. The company is testing its resilience to extreme outdoor weather conditions in anticipation of deployment in Manitoba, Canada. Per the update, the fully climatized containerized modules continue to operate efficiently under winter conditions. “FuelPositive has successfully built our containerized modules as fully climatized systems, capable of working in extreme temperatures, ranging from minus 50 C to plus 45 C. The units are temperature controlled and built to the strictest hazardous area classifications with redundant monitoring. Our systems are engineered to run without…

Continue Reading

FridayFeb 17, 2023 12:54 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-CBD Demonstrates ~1,900% Better Permeability Through Skin

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced its 28th granted patent worldwide and the first granted patent from its sixth patent family, titled Transdermal And/or Dermal Delivery of Lipophilic Active Agents. “The Canadian patent #3,093,414 is for improved compositions and methods for transdermal and dermal delivery of cannabinoids, including cannabidiol (‘CBD’) and tetrahydrocannabinol (‘THC’), all established on the company’s patented DehydraTECH technology,” a recent article reads. “In Lexaria’s 2018 study, DehydraTECH-CBD demonstrated almost a 1,900% increase in CBD permeability through human skin compared to a control formulation that was devoid of any commercial…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered